A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML
MEI Pharma, Inc.
MEI Pharma, Inc.
Novartis
Century Therapeutics, Inc.
Boston University
Assistance Publique - Hôpitaux de Paris
Regeneron Pharmaceuticals
Roswell Park Cancer Institute
University of Washington
AbbVie
Adicet Therapeutics
University of California, Davis
Celgene
Columbia University
Dana-Farber Cancer Institute
Janssen Research & Development, LLC
Zhejiang DTRM Biopharma
MEI Pharma, Inc.
Amgen
Fondazione Italiana Linfomi - ETS
MEI Pharma, Inc.
Genmab
Academic and Community Cancer Research United
Xenikos
TG Therapeutics, Inc.
IGM Biosciences, Inc.
MingSight Pharmaceuticals, Inc
AHS Cancer Control Alberta
Altor BioScience
University of California, San Francisco
University of Chicago
Ipsen
Amgen
Swiss Cancer Institute
Memorial Sloan Kettering Cancer Center
Prelude Therapeutics
Stanford University
ADC Therapeutics S.A.
SecuraBio
SecuraBio
University of Nebraska
University of Nebraska
Gilead Sciences
Washington University School of Medicine
OM Pharma SA
TG Therapeutics, Inc.
Augusta University
University of Washington
Eastern Cooperative Oncology Group
Swiss Cancer Institute
Asana BioSciences